Shopping Cart
- Remove All
- Your shopping cart is currently empty
Utreloxastat (PTC857) is a novel 15-lipoxygenase inhibitor that can be used to study amyotrophic lateral sclerosis
.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $93 | In Stock | |
5 mg | $228 | In Stock | |
10 mg | $328 | In Stock | |
25 mg | $562 | In Stock | |
50 mg | $828 | In Stock | |
100 mg | $1,450 | In Stock | |
200 mg | $1,950 | In Stock | |
1 mL x 10 mM (in DMSO) | $248 | In Stock |
Description | Utreloxastat (PTC857) is a novel 15-lipoxygenase inhibitor that can be used to study amyotrophic lateral sclerosis . |
Alias | PTC857, EPI 857 |
Molecular Weight | 276.41 |
Formula | C18H28O2 |
Cas No. | 1213269-96-5 |
Smiles | CCCCCCCCCC1=C(C)C(=O)C(C)=C(C)C1=O |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 30 mg/mL (108.53 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.